Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Provincial insurance plans like Ontario's OHIP or BC's PharmaCare usually only cover Saxenda for managing Type 2 diabetes
CJC-1295 Description: GHRH analog
Mounjaro (tirzepatide): A GLP-1/GIP dual agonist medication indicated for type 2 diabetes, while its counterpart Zepbound focuses on weight loss
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
US$ 22.25
US$ 26.58
US$ 27.00
US$ 28.13
